HLS

HEALIUS FPO [HLS]
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Healthcare · ASX Small Cap
$0.4600 +7.0%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when HLS triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track HLS — Free

Active Signals

Bullish Signals

  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Trading above both moving averages — the trend is your friend here
  • Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.2x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (17% of range)
  • Elevated short interest (8.5%)
  • CANSLIM I: Institutional ownership (111%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 52% over the past year
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.84%/day)
  • Altman Z-Score distress zone (1.37 < 1.81, low-confidence approx)
  • Days to cover very high (15.3)
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Deeply negative margins (-30%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about HLS
"What's driving HLS today?" "How does HLS compare to peers?" "Key risks for HLS?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change in substantial holding
NONE Change in substantial holding
NONE Change of Director's Interest Notice - Charlie Taylor
Announcement tone +3pts

Recent ASX Announcements

2026-09-03 Change in substantial holding
2026-08-28 Change in substantial holding
2026-08-27 Change of Director's Interest Notice - Charlie Taylor
2026-08-27 Change of Director's Interest Notice - Sally Evans
2026-08-27 Change of Director's Interest Notice - Kathy Ostin

Key Metrics

$312.3M
Market Cap
4.0M
Avg Volume
0.8x
Vol Ratio
$0.30 — $1.07
52-Week Range
8.5%
Short Interest
N/A
Cash Runway
-107.7%
ROE
-30.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 78%
LLeader vs LaggardpassRS: 14
IInstitutional SponsorshippassInst: 111%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:HLS vs REGHLS vs CANHLS vs BIT
Scout Pro — Deeper Analysis for HLS
Try Pro free for 30 days
Share this analysis

Track HLS and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required